TMCnet News
Bioinformatics Market Analysis, Developments and Forecasts 2016-2026LONDON, October 10, 2016 /PRNewswire/ -- Revenue Predictions for Genomics, Metabolomics, Proteomics, Transcriptomics, Chemoinformatics and Drug Discovery Applications; Sales Breakdowns for the US, EU, Japan, China and India; and Discussion of Personalised Medicine, Pharmacogenomics, Next-Generation Sequencing, Diagnostic Biomarkers and Big Data The Rising Bioinformatics Market - Introducing Your Guide to its Sales Potentials Do you lack data on bioinformatics to help your research, plans and presentations? Discover in our report where that industry heads, avoiding struggles to find information you need. Our investigation forecasts revenues to 2026 at overall world market, submarket and regional level, showing what bioinformatics companies and their industry can achieve. Please read on to explore that computer software industry aiding molecular biology and see what its future market could be worth. Forecasts to 2026 and discussions on bioinformatics to save you time and help you succeed Discover what is possible. Besides revenue forecasting to 2026, our new study shows you results, sales growth rates and market shares. You also explore trends, R&D and leading companies. That 86 page work gives 19 tables, 24 charts and a research interview. With that knowledge you could benefit your analyses, decisions and authority. Make your work easier and discover how you could save time and benefit your reputation for commercial insight. Bioinformatics holds great promise from 2016 to benefit its suppliers and users. Forecasting of that world market and submarkets - what does the future hold? To see a report overview please email Sara Peerun on [email protected] Which systems and applications will generate most revenue from 2016 to 2026? With our investigation you assess those outlooks for sales expansion, seeing where you could gain. See what is happening in that information technology to manipulate and analyse biological and pharmaceutical data. In our study you also explore opportunities for selling those computer software systems for analysing biological data in developed and developing countries. Assess needs and possibilities, seeing what is possible. National markets - where will highest revenues and fastest growth occur? Our analysis shows you individual revenue forecasts to 2026 for these regions and countries: The new study shows regions with highest revenues, demand and sales potentials. You discover prospects for companies, appraising bioinformatic needs, demands and uses. Explore the possibilities for sustaiing technological and commercial advances. That way you discover what is possible. Our investigation also shows you qualitative analyses. Explore trends and opportunities, finding what they mean for that industry. Events and forces influencing bioinformatics developers, producers and marketers Our report discusses other forces influencing that market, including these: In our study you examine what stimulates and restrains that informatics market. That way you explore, from 2016, how bioinformatics companies, medical researchers and drug developers in large and specialist pharmaceutical companies can benefit. Companies and overall 2020 market value - how high can revenues go? The report explores activities, progress, deals and outlooks of leading companies, including these organisations: You also see our interview with QIAGEN. With our survey you assess what bioinformatics specialists do and how they progress, helping you stay ahead in knowledge to aid success. Main ways Bioinformatics Market Analysis, Developments and Forecasts 2016-2026 benefits your work That study, by our in-house team in the UK, gives knowledge to benefit your planning, decisions and presentations. It shows data you find nowhere else, helping you stay ahead. Trying our analysis now lets you see bioinformatic sales opportunities and predictions With our investigation you are less likely to fall behind in information or miss opportunity. Discover how you could save time and effort in your work, also benefiting your influence on that rising industry. Avoid missing out on knowledge to benefit your work. Please get our new report here now, helping you stay ahead and succeed. To see a report overview please email Sara Peerun on [email protected] To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100 Or click on https://www.visiongain.com/Report/1739/Bioinformatics-Market-Analysis-Developments-and-Forecasts-2016-2026 Organisations Mentioned in the Report 100,000 Genomes Project 3rd Millennium Affymetrix Agilent Technologies Alphabet Amazon Applied Biosystems AstraZeneca AstridBio Baylor College of Medicine BioBam BIOBASE Biomatters BioNano Genomics BIOVIA (formerly Accelrys) BlueGnome Burning Rock Canada Foundation for Innovation Cancer Moonshot Task Force Centre for Genomics Research [HLI] CLC Bio Compugen Dassault Systèmes DNAnexus DNASTAR DOE (Department of Energy) [US] FEI Company Finnish Institute for Molecular Medicine Garvan Institute of Medical Research GDC (Genomic Data Commons) Geisinger Health Systems Genentech (subsidiary of Roche) Genome.One (subsidiary of Garvan Institute of Medical Research) Genomics England Genomics plc Geospiza GIS (Genome Institute of Singapore) Harvard School of Medicine Health Education England HGP (Human Genome Project) HGSC (Human Genome Sequencing Center) [Baylor College of Medicine] HLI (Human Longevity Inc) Illumina Ingenuity Systems Integromics (subsidiary of PerkinElmer Informatics) Invitrogen Corporation LabCorp Life Technologies (now renamed Thermo Fisher Scientific) Memorial Sloan Kettering Cancer Center MyCode Community Health Initiative [Geisinger Health Systems] NCI (National Cancer Institute) [US] NHS (National Health Service) [UK] NIH (National Institute for Health Research) [UK] Novogene Ocimum Biosolutions PerkinElmer PerkinElmer Informatics (formerly CambridgeSoft Corporation, now subsidiary of PerkinElmer) POLARIS (Personalised OMIC Lattice for Advanced Research and Improving Stratification) QIAGEN Regeneron Regeneron Genetics Center Roche Sanger Centre Saudi Genome Project SCGPM (Stanford Center for Genomics and Personalised Medicine) Solexa Strand Lifesciences (subsidiary of Syngene International) Syngene International Thermo Fisher Scientific University of California University of Toronto US National Human Genome Research Institute VA (Department of Veterans Affairs) [US] Verily Life Sciences (subsidiary of Alphabet) Virginia Commonwealth University Wellcome Trust Sanger Institute WuXi NextCODE Genomics (subsidiary of WuXi PharmaTech) WuXi PharmaTech To see a report overview please email Sara Peerun on [email protected] 
|